ClinicalTrials.gov record
Completed Phase 2 Interventional

Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease

ClinicalTrials.gov ID: NCT00031720

Public ClinicalTrials.gov record NCT00031720. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 9:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of Soy Protein to Treat Vasomotor Symptoms in Postmenopausal Women Taking Tamoxifen

Study identification

NCT ID
NCT00031720
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
112 participants

Conditions and interventions

Interventions

  • Placebo Other
  • Tamoxifen Drug
  • isoflavones Dietary Supplement
  • soy protein Dietary Supplement

Other · Drug · Dietary Supplement

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2002
Primary completion
Mar 31, 2006
Completion
Oct 31, 2013
Last update posted
Jul 12, 2016

2002 – 2013

United States locations

U.S. sites
14
U.S. states
6
U.S. cities
12
Facility City State ZIP Site status
Center for Cancer Care at OSF Saint Anthony Medical Center Rockford Illinois 61108
Elkhart General Hospital Elkhart Indiana 46515
Howard Community Hospital Kokomo Indiana 46904
Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte Indiana 46350
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601
Memorial Hospital of South Bend South Bend Indiana 46601
Saint Joseph Regional Medical Center South Bend Indiana 46617
Commonwealth Hematology-Oncology, PC - Worcester Worcester Massachusetts 01605
Lakeland Regional Cancer Care Center - St. Joseph Saint Joseph Michigan 49085
Kingsbury Center for Cancer Care at Cheshire Medical Center Keene New Hampshire 03431
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756-0002
Wayne Memorial Hospital, Incorporated Goldsboro North Carolina 27534
Kinston Medical Specialists Kinston North Carolina 28501
FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center Pinehurst North Carolina 28374

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00031720, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2016 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00031720 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →